From: The prognostic role of pre-treatment neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy
Prognostic factors
Overall-Survival
Odds ratio
95% CI
p
NLR
0.539
0.414–0.701
0.000
PLR
0.712
0.548–0.925
0.011
TNM stage
1.481
1.113–1.971
0.007
Tumor length
0.960
0.726–1.271
0.777